Scissortail Wealth Management LLC Has $605,000 Holdings in Waters Co. (NYSE:WAT)

Scissortail Wealth Management LLC increased its stake in Waters Co. (NYSE:WAT - Free Report) by 40,650.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,630 shares of the medical instruments supplier's stock after purchasing an additional 1,626 shares during the period. Scissortail Wealth Management LLC's holdings in Waters were worth $605,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Barclays PLC increased its stake in Waters by 34.8% during the 3rd quarter. Barclays PLC now owns 159,995 shares of the medical instruments supplier's stock valued at $57,579,000 after buying an additional 41,339 shares during the period. Wedmont Private Capital bought a new stake in shares of Waters in the 4th quarter worth $202,000. Park Avenue Securities LLC lifted its holdings in shares of Waters by 19.8% in the fourth quarter. Park Avenue Securities LLC now owns 2,531 shares of the medical instruments supplier's stock valued at $939,000 after buying an additional 419 shares during the period. Tompkins Financial Corp bought a new position in Waters during the fourth quarter valued at about $148,000. Finally, Procyon Advisors LLC grew its holdings in Waters by 49.9% during the fourth quarter. Procyon Advisors LLC now owns 994 shares of the medical instruments supplier's stock worth $369,000 after acquiring an additional 331 shares during the period. Institutional investors and hedge funds own 94.01% of the company's stock.

Analysts Set New Price Targets

WAT has been the topic of several recent research reports. Baird R W raised shares of Waters from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, March 26th. KeyCorp upgraded shares of Waters from a "sector weight" rating to an "overweight" rating and set a $460.00 price target on the stock in a research report on Monday, March 31st. Sanford C. Bernstein set a $400.00 price objective on Waters and gave the company an "outperform" rating in a research report on Wednesday, April 16th. Robert W. Baird raised their price objective on Waters from $355.00 to $374.00 and gave the stock an "outperform" rating in a research note on Wednesday, May 7th. Finally, JPMorgan Chase & Co. lifted their target price on Waters from $380.00 to $390.00 and gave the stock a "neutral" rating in a report on Thursday, March 6th. Nine research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $390.19.

Waters Stock Performance

WAT traded up $1.26 during trading on Thursday, reaching $348.62. 150,431 shares of the company's stock were exchanged, compared to its average volume of 479,222. Waters Co. has a fifty-two week low of $279.24 and a fifty-two week high of $423.56. The company has a quick ratio of 0.65, a current ratio of 0.94 and a debt-to-equity ratio of 1.14. The company has a market capitalization of $20.75 billion, a P/E ratio of 32.57, a PEG ratio of 3.79 and a beta of 1.14. The business has a 50 day moving average price of $345.76 and a 200 day moving average price of $371.10.

Waters (NYSE:WAT - Get Free Report) last announced its quarterly earnings results on Tuesday, May 6th. The medical instruments supplier reported $2.25 EPS for the quarter, beating the consensus estimate of $2.22 by $0.03. The business had revenue of $661.71 million for the quarter, compared to analyst estimates of $655.50 million. Waters had a return on equity of 46.31% and a net margin of 21.56%. Waters's quarterly revenue was up 3.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.21 EPS. As a group, analysts predict that Waters Co. will post 12.86 earnings per share for the current fiscal year.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.